Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Nov;36(11):2487–2492. doi: 10.1128/aac.36.11.2487

Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.

E Brummer 1, P R Bhagavathula 1, L H Hanson 1, D A Stevens 1
PMCID: PMC284359  PMID: 1336949

Abstract

We examined in vitro interaction between the azole antifungal agents itraconazole and ketoconazole and macrophages and their activities against Blastomyces dermatitidis. Fungistatic and fungicidal concentrations for B. dermatitidis in vitro were assessed in a microculture system in which fungistasis was measured as inhibition of multiplication and fungicidal activity was measured as reduction of inoculum CFU. Resident peritoneal murine macrophages, which surround but do not phagocytize the fungus, were not fungicidal for B. dermatitidis isolates but were fungistatic for some isolates studied. Synergy was demonstrated when fungistatic concentrations (e.g., 0.01 micrograms/ml) of itraconazole, which limited growth 55% compared with that of controls, were cocultured with macrophages; this resulted in fungicidal activity (85% killing) against B. dermatitidis (ATCC 26199) in 72-h assays. This synergy could occur even if itraconazole was added after the macrophages had surrounded the fungus. Ketoconazole at fungistatic concentrations did not act synergistically with macrophages to kill B. dermatitidis. Lymph node lymphocytes could not substitute for macrophages in synergy with itraconazole to kill B. dermatitidis. When B. dermatitidis was separated by a filter from macrophages in Transwell cultures, fungicidal synergy with itraconazole was less efficient. Pretreatment of B. dermatitidis with itraconazole for 24 h did not render the fungus susceptible to killing by macrophages in the absence of itraconazole, whereas pretreatment of nonfungistatic macrophages with itraconazole rendered them fungistatic in a dose-dependent manner. Three other isolates were killed by otherwise fungistatic concentrations of itraconazole when the isolates were cocultured with macrophages. These findings indicate that one basis for the efficacy of itraconazole versus ketoconazole in treating blastomycosis could be synergy of a fungistatic concentration of itraconazole with macrophages in killing of B. dermatitidis.

Full text

PDF
2492

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aerts F., Van Cutsem J., De Brabander M. The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes. Mykosen. 1986 Apr;29(4):165–176. [PubMed] [Google Scholar]
  2. Arathoon E. G., Brummer E., Stevens D. A. Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole. Mycoses. 1989;32 (Suppl 1):109–112. doi: 10.1111/j.1439-0507.1989.tb02300.x. [DOI] [PubMed] [Google Scholar]
  3. Bauer T. M., Kronsteiner W., Bassler M., Daschner F. D. Sensitivity testing with ketoconazole in an assay containing Candida albicans, human polymorphonuclear leukocytes and serum. Eur J Clin Microbiol. 1986 Dec;5(6):665–668. doi: 10.1007/BF02013296. [DOI] [PubMed] [Google Scholar]
  4. Brass C., Shainhouse J. Z., Stevens D. A. Variability of agar dilution-replicator method of yeast susceptibility testing. Antimicrob Agents Chemother. 1979 Jun;15(6):763–768. doi: 10.1128/aac.15.6.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brummer E., Morozumi P. A., Philpott D. E., Stevens D. A. Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect Immun. 1981 May;32(2):864–871. doi: 10.1128/iai.32.2.864-871.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Claus R., Nausch M., Ringel B., Zingler C., Schulze H. A., Kaben U. Wirkungen von Ketoconazol auf das Immunsystem: IV. In vitro-Effekte auf Monozytenfunktionen. Mycoses. 1988 Jun;31(6):303–312. [PubMed] [Google Scholar]
  7. Farkas B., Dobozy A. The effect of ketoconazole on the phagocytosis and intracellular killing of Candida albicans by polymorphonuclear granulocytes. Mykosen. 1983 Jan;26(1):22–26. doi: 10.1111/j.1439-0507.1983.tb03932.x. [DOI] [PubMed] [Google Scholar]
  8. Ganer A., Arathoon E., Stevens D. A. Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole. Rev Infect Dis. 1987 Jan-Feb;9 (Suppl 1):S77–S86. doi: 10.1093/clinids/9.supplement_1.s77. [DOI] [PubMed] [Google Scholar]
  9. Harvey R. P., Schmid E. S., Carrington C. C., Stevens D. A. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am Rev Respir Dis. 1978 Apr;117(4):695–703. doi: 10.1164/arrd.1978.117.4.695. [DOI] [PubMed] [Google Scholar]
  10. Heykants J., Van Peer A., Van de Velde V., Van Rooy P., Meuldermans W., Lavrijsen K., Woestenborghs R., Van Cutsem J., Cauwenbergh G. The clinical pharmacokinetics of itraconazole: an overview. Mycoses. 1989;32 (Suppl 1):67–87. doi: 10.1111/j.1439-0507.1989.tb02296.x. [DOI] [PubMed] [Google Scholar]
  11. Johnson E. M., Warnock D. W., Richardson M. D., Douglas C. J. In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils. J Antimicrob Chemother. 1986 Jul;18(1):83–91. doi: 10.1093/jac/18.1.83. [DOI] [PubMed] [Google Scholar]
  12. Klein B. S., Vergeront J. M., Weeks R. J., Kumar U. N., Mathai G., Varkey B., Kaufman L., Bradsher R. W., Stoebig J. F., Davis J. P. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med. 1986 Feb 27;314(9):529–534. doi: 10.1056/NEJM198602273140901. [DOI] [PubMed] [Google Scholar]
  13. Odds F. C., Webster C. E. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. J Antimicrob Chemother. 1988 Oct;22(4):473–481. doi: 10.1093/jac/22.4.473. [DOI] [PubMed] [Google Scholar]
  14. Perfect J. R., Granger D. L., Durack D. T. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis. 1987 Aug;156(2):316–323. doi: 10.1093/infdis/156.2.316. [DOI] [PubMed] [Google Scholar]
  15. Roilides E., Walsh T. J., Rubin M., Venzon D., Pizzo P. A. Effects of antifungal agents on the function of human neutrophils in vitro. Antimicrob Agents Chemother. 1990 Feb;34(2):196–201. doi: 10.1128/aac.34.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rowan-Kelly B., Ferrante A., Thong Y. H. Modification of polymorphonuclear leucocyte function by imidazoles. Int J Immunopharmacol. 1984;6(4):389–393. doi: 10.1016/0192-0561(84)90059-6. [DOI] [PubMed] [Google Scholar]
  17. Van 't Wout J. W., Meynaar I., Linde I., Poell R., Mattie H., Van Furth R. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages. J Antimicrob Chemother. 1990 May;25(5):803–811. doi: 10.1093/jac/25.5.803. [DOI] [PubMed] [Google Scholar]
  18. de Brabander M., Aerts F., van Cutsem J., van den Bossche H., Borgers M. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia. 1980 Sep;18(3):197–210. doi: 10.1080/00362178085380351. [DOI] [PubMed] [Google Scholar]
  19. van Rensburg C. E., Anderson R., Jooné G., van der Merwe M. F., Eftychis H. A. The effects of ketoconazole on cellular and humoral immune functions. J Antimicrob Chemother. 1983 Jan;11(1):49–55. doi: 10.1093/jac/11.1.49. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES